Suppr超能文献

甲状腺乳头状癌的风险组分层及预后因素

Risk group stratification and prognostic factors in papillary carcinoma of thyroid.

作者信息

Shaha A R, Shah J P, Loree T R

机构信息

Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

出版信息

Ann Surg Oncol. 1996 Nov;3(6):534-8. doi: 10.1007/BF02306085.

Abstract

BACKGROUND

Our understanding of the natural history of differentiated thyroid carcinoma has improved with the definition of prognostic factors. These prognostic factors have helped us identify patients in various risk groups.

METHODS

A retrospective review of a consecutive series of 810 previously untreated patients with papillary carcinoma of the thyroid was undertaken to analyze the prognostic factors and risk groups. There were 403 patients in the low-risk group, 313 in the intermediate group, and 94 classified in the high-risk group.

RESULTS

With a median follow-up of 20 years, 99% survival was achieved in the low-risk group, whereas only 43% survived in the high-risk group. The intermediate-risk group had a 20-year survival of 83%. The favorable prognostic factors included female sex, young age, absence of distant metastases and extrathyroidal extension of the disease, size < 4 cm, and low-grade histology. Focality, presence of lymph node metastasis, and pure papillary or mixed variant had no statistical significance on prognosis.

CONCLUSIONS

Based on various prognostic factors, low-, intermediate-, and high-risk groups are identified. Patients in the low-risk group have excellent survival (99%). Appropriate selection of surgical and adjuvant treatment should therefore be used based on prognostic factors and risk group stratification.

摘要

背景

随着预后因素的明确,我们对分化型甲状腺癌自然史的认识有所提高。这些预后因素帮助我们识别出处于不同风险组的患者。

方法

对连续810例未经治疗的甲状腺乳头状癌患者进行回顾性分析,以分析预后因素和风险组。低风险组有403例患者,中风险组有313例,高风险组有94例。

结果

中位随访20年,低风险组的生存率为99%,而高风险组仅43%存活。中风险组20年生存率为83%。有利的预后因素包括女性、年轻、无远处转移和疾病的甲状腺外侵犯、肿瘤大小<4 cm以及低级别组织学。病灶范围、存在淋巴结转移以及纯乳头状或混合亚型对预后无统计学意义。

结论

基于各种预后因素,确定了低、中、高风险组。低风险组患者的生存率极佳(99%)。因此,应根据预后因素和风险组分层适当选择手术和辅助治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验